-
1
-
-
84862007266
-
Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines
-
Nelson G., Marconi P., Periolo O., La Torre J., Alvarez MaA. Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines. Vaccine 2012, 30:4499-4504.
-
(2012)
Vaccine
, vol.30
, pp. 4499-4504
-
-
Nelson, G.1
Marconi, P.2
Periolo, O.3
La Torre, J.4
Alvarez, M.5
-
2
-
-
0032969826
-
Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections
-
Houe H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet Microbiol 1999, 64:89-107.
-
(1999)
Vet Microbiol
, vol.64
, pp. 89-107
-
-
Houe, H.1
-
3
-
-
58549117343
-
Evaluation of economic effects and the health and performance of the general cattle population after exposure to cattle persistently infected with bovine viral diarrhea virus in a starter feedlot
-
Hessman B.E., Fulton R.W., Sjeklocha D.B., Murphy T.A., Ridpath J.F., Payton M.E. Evaluation of economic effects and the health and performance of the general cattle population after exposure to cattle persistently infected with bovine viral diarrhea virus in a starter feedlot. Am J Vet Res 2009, 70:73-85.
-
(2009)
Am J Vet Res
, vol.70
, pp. 73-85
-
-
Hessman, B.E.1
Fulton, R.W.2
Sjeklocha, D.B.3
Murphy, T.A.4
Ridpath, J.F.5
Payton, M.E.6
-
4
-
-
84907267382
-
-
Health Department of agriculture, Safeguarding American Agriculture, Colorado: United States, CfEaA (Ed.)
-
Services V. Bovine viral diarrhea virus. Health December 2007, Department of agriculture, Safeguarding American Agriculture, Colorado: United States. CfEaA (Ed.).
-
(2007)
-
-
-
5
-
-
34347335565
-
Bovine viral diarrhea virus (BVDV): epidemiologic concerns relative to semen and embryos
-
Gard J.A., Givens M.D., Stringfellow D.A. Bovine viral diarrhea virus (BVDV): epidemiologic concerns relative to semen and embryos. Theriogenology 2007, 68:434-442.
-
(2007)
Theriogenology
, vol.68
, pp. 434-442
-
-
Gard, J.A.1
Givens, M.D.2
Stringfellow, D.A.3
-
6
-
-
0023850760
-
Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56 K to 58 K glycoprotein
-
Donis R.O., Corapi W., Dubovi E.J. Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56 K to 58 K glycoprotein. J Gen Virol 1988, 69(Pt. 1):77-86.
-
(1988)
J Gen Virol
, vol.69
, pp. 77-86
-
-
Donis, R.O.1
Corapi, W.2
Dubovi, E.J.3
-
7
-
-
84859853846
-
Yeast-surface expressed BVDV E2 protein induces a Th1/Th2 response in naive T cells
-
Patterson R., Nerren J., Kogut M., Court P., Villarreal-Ramos B., Seyfert H.-M., et al. Yeast-surface expressed BVDV E2 protein induces a Th1/Th2 response in naive T cells. Dev Comp Immunol 2012, 37:107-114.
-
(2012)
Dev Comp Immunol
, vol.37
, pp. 107-114
-
-
Patterson, R.1
Nerren, J.2
Kogut, M.3
Court, P.4
Villarreal-Ramos, B.5
Seyfert, H.-M.6
-
8
-
-
84866664003
-
Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle
-
Pecora A., Aguirreburualde M.S., Aguirreburualde A., Leunda M.R., Odeon A., Chiavenna S., et al. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle. Vet Res Commun 2012, 36:157-164.
-
(2012)
Vet Res Commun
, vol.36
, pp. 157-164
-
-
Pecora, A.1
Aguirreburualde, M.S.2
Aguirreburualde, A.3
Leunda, M.R.4
Odeon, A.5
Chiavenna, S.6
-
9
-
-
70049116833
-
Analysis of variability and antigenic peptide prediction of E2 BVDV glycoprotein in a mucosal-disease affected animal
-
Ciulli S., Galletti E., Battilani M., Galligioni V., Prosperi S. Analysis of variability and antigenic peptide prediction of E2 BVDV glycoprotein in a mucosal-disease affected animal. Vet Res Commun 2009, 33(Suppl. 1):125-127.
-
(2009)
Vet Res Commun
, vol.33
, pp. 125-127
-
-
Ciulli, S.1
Galletti, E.2
Battilani, M.3
Galligioni, V.4
Prosperi, S.5
-
10
-
-
0029802802
-
Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease
-
Bolin S.R., Ridpath J.F. Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch Virol 1996, 141:1463-1477.
-
(1996)
Arch Virol
, vol.141
, pp. 1463-1477
-
-
Bolin, S.R.1
Ridpath, J.F.2
-
11
-
-
79953804248
-
Toth. I. Peptide-based subunit nanovaccines
-
Skwarczynski M. Toth. I. Peptide-based subunit nanovaccines. Curr Drug Deliv 2011, 8:282-289.
-
(2011)
Curr Drug Deliv
, vol.8
, pp. 282-289
-
-
Skwarczynski, M.1
-
12
-
-
80052422744
-
Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems
-
Foged C. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Ther Deliv 2011, 2:1057-1077.
-
(2011)
Ther Deliv
, vol.2
, pp. 1057-1077
-
-
Foged, C.1
-
13
-
-
79959709054
-
Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice
-
Wen Z.S., Xu Y.L., Zou X.T., Xu Z.R. Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Mar Drugs 2011, 9:1038-1055.
-
(2011)
Mar Drugs
, vol.9
, pp. 1038-1055
-
-
Wen, Z.S.1
Xu, Y.L.2
Zou, X.T.3
Xu, Z.R.4
-
14
-
-
0031661414
-
QS-21: a water-soluble triterpene glycoside adjuvant
-
Kensil C.R., Kammer R. QS-21: a water-soluble triterpene glycoside adjuvant. Expert Opin Investig Drugs 1998, 7:1475-1482.
-
(1998)
Expert Opin Investig Drugs
, vol.7
, pp. 1475-1482
-
-
Kensil, C.R.1
Kammer, R.2
-
15
-
-
33748795114
-
Saponin-adjuvanted particulate vaccines for clinical use
-
Skene C.D., Sutton P. Saponin-adjuvanted particulate vaccines for clinical use. Methods 2006, 40:53-59.
-
(2006)
Methods
, vol.40
, pp. 53-59
-
-
Skene, C.D.1
Sutton, P.2
-
16
-
-
58149216348
-
New horizons in adjuvants for vaccine development
-
Reed S.G., Bertholet S., Coler R.N., Friede M. New horizons in adjuvants for vaccine development. Trends Immunol 2009, 30:23-32.
-
(2009)
Trends Immunol
, vol.30
, pp. 23-32
-
-
Reed, S.G.1
Bertholet, S.2
Coler, R.N.3
Friede, M.4
-
17
-
-
33748697487
-
Structure-acitivity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis induction
-
Chwalek M., Lalun N., Bobichon H., Ple K., Voutquenne-Nazabadioko L. Structure-acitivity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis induction. Biochim Biophys Acta 2006, 1760:1418-1427.
-
(2006)
Biochim Biophys Acta
, vol.1760
, pp. 1418-1427
-
-
Chwalek, M.1
Lalun, N.2
Bobichon, H.3
Ple, K.4
Voutquenne-Nazabadioko, L.5
-
18
-
-
84913873825
-
Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil
-
Freund J., Casals J., Hosmer E. Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proc Soc Exp Biol Med 1937, 37:509-513.
-
(1937)
Proc Soc Exp Biol Med
, vol.37
, pp. 509-513
-
-
Freund, J.1
Casals, J.2
Hosmer, E.3
-
19
-
-
0037205174
-
Mechanisms of stimulation of the immune response by aluminum adjuvants
-
HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 2002, 3(20 Suppl.):S34-S39.
-
(2002)
Vaccine
, vol.3
, pp. S34-S39
-
-
Hogen Esch, H.1
-
20
-
-
0026443146
-
The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants
-
Bomford R., Stapleton M., Winsor S., McKnight A., Andronova T. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. AIDS Res Hum Retroviruses 1992, 8:1765-1771.
-
(1992)
AIDS Res Hum Retroviruses
, vol.8
, pp. 1765-1771
-
-
Bomford, R.1
Stapleton, M.2
Winsor, S.3
McKnight, A.4
Andronova, T.5
-
21
-
-
0030963532
-
In vivo induction of type 1 and 2 immune responses against protein antigens
-
Comoy E.E., Capron A., Thyphronitis G. In vivo induction of type 1 and 2 immune responses against protein antigens. Int Immunol 1997, 9:523-531.
-
(1997)
Int Immunol
, vol.9
, pp. 523-531
-
-
Comoy, E.E.1
Capron, A.2
Thyphronitis, G.3
-
22
-
-
84899648022
-
Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery
-
Popat A., Jambhrunkar S., Zhang J., Yang J., Zhang H., Meka A., et al. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery. Chem Commun (Camb) 2014, 50:5547-5550.
-
(2014)
Chem Commun (Camb)
, vol.50
, pp. 5547-5550
-
-
Popat, A.1
Jambhrunkar, S.2
Zhang, J.3
Yang, J.4
Zhang, H.5
Meka, A.6
-
23
-
-
84901770439
-
In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles
-
Mahony D., Cavallaro A.S., Mody K.T., Xiong L., Mahony T.J., Qiao S.Z., et al. In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles. Nanoscale 2014, 6:6617-6626.
-
(2014)
Nanoscale
, vol.6
, pp. 6617-6626
-
-
Mahony, D.1
Cavallaro, A.S.2
Mody, K.T.3
Xiong, L.4
Mahony, T.J.5
Qiao, S.Z.6
-
24
-
-
84898597476
-
Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions
-
Mody K.T., Mahony D., Cavallaro A.S., Stahr F., Qiao S.Z., Mahony T.J., et al. Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions. Int J Pharm 2014, 465:325-332.
-
(2014)
Int J Pharm
, vol.465
, pp. 325-332
-
-
Mody, K.T.1
Mahony, D.2
Cavallaro, A.S.3
Stahr, F.4
Qiao, S.Z.5
Mahony, T.J.6
-
25
-
-
84884227222
-
Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice
-
Mahony D., Cavallaro A.S., Stahr F., Mahony T.J., Qiao S.Z., Mitter N. Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice. Small 2013, 9:3138-3146.
-
(2013)
Small
, vol.9
, pp. 3138-3146
-
-
Mahony, D.1
Cavallaro, A.S.2
Stahr, F.3
Mahony, T.J.4
Qiao, S.Z.5
Mitter, N.6
-
26
-
-
79960173354
-
Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers
-
Popat A., Hartono S.B., Stahr F., Liu J., Qiao S.Z., Qing Lu G. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale 2011, 3:2801-2818.
-
(2011)
Nanoscale
, vol.3
, pp. 2801-2818
-
-
Popat, A.1
Hartono, S.B.2
Stahr, F.3
Liu, J.4
Qiao, S.Z.5
Qing Lu, G.6
-
27
-
-
84856729725
-
Adsorption and release of biocides with mesoporous silica nanoparticles
-
Popat A., Liu J., Hu Q., Kennedy M., Peters B., Lu G.Q., et al. Adsorption and release of biocides with mesoporous silica nanoparticles. Nanoscale 2012, 4:970-975.
-
(2012)
Nanoscale
, vol.4
, pp. 970-975
-
-
Popat, A.1
Liu, J.2
Hu, Q.3
Kennedy, M.4
Peters, B.5
Lu, G.Q.6
-
28
-
-
84878714022
-
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery
-
Mody K.T., Popat A., Mahony D., Cavallaro A.S., Yu C., Mitter N. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery. Nanoscale 2013, 5167-5179.
-
(2013)
Nanoscale
, pp. 5167-5179
-
-
Mody, K.T.1
Popat, A.2
Mahony, D.3
Cavallaro, A.S.4
Yu, C.5
Mitter, N.6
-
29
-
-
84876806823
-
Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant
-
Liu T., Liu H., Fu C., Li L., Chen D., Zhang Y., et al. Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant. J Colloid Interface Sci 2013, 400:168-174.
-
(2013)
J Colloid Interface Sci
, vol.400
, pp. 168-174
-
-
Liu, T.1
Liu, H.2
Fu, C.3
Li, L.4
Chen, D.5
Zhang, Y.6
-
30
-
-
84863643546
-
Adjuvant properties of mesoporous silica particles tune the development of effector T cells
-
Vallhov H., Kupferschmidt N., Gabrielsson S., Paulie S., Stromme M., Garcia-Bennett A.E., et al. Adjuvant properties of mesoporous silica particles tune the development of effector T cells. Small 2012, 8:2116-2124.
-
(2012)
Small
, vol.8
, pp. 2116-2124
-
-
Vallhov, H.1
Kupferschmidt, N.2
Gabrielsson, S.3
Paulie, S.4
Stromme, M.5
Garcia-Bennett, A.E.6
-
31
-
-
38949139820
-
Synthesis and stealthing study of bare and PEGylated silica micro- and nanoparticles as potential drug-delivery vectors
-
Yague C., Moros M., Grazu V., Arruebo M., Santamaria J. Synthesis and stealthing study of bare and PEGylated silica micro- and nanoparticles as potential drug-delivery vectors. Chem Eng J 2008, 137:45-53.
-
(2008)
Chem Eng J
, vol.137
, pp. 45-53
-
-
Yague, C.1
Moros, M.2
Grazu, V.3
Arruebo, M.4
Santamaria, J.5
-
32
-
-
78649445464
-
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15
-
Carvalho L.V., Ruiz Rde C., Scaramuzzi K., Marengo E.B., Matos J.R., Tambourgi D.V., et al. Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15. Vaccine 2010, 28:7829-7836.
-
(2010)
Vaccine
, vol.28
, pp. 7829-7836
-
-
Carvalho, L.V.1
Ruiz Rde, C.2
Scaramuzzi, K.3
Marengo, E.B.4
Matos, J.R.5
Tambourgi, D.V.6
-
33
-
-
34548434374
-
Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins
-
Slowing, Trewyn B.G., Lin V.S.Y. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 2007, 129:8845-8849.
-
(2007)
J Am Chem Soc
, vol.129
, pp. 8845-8849
-
-
Slowing, T.B.G.1
Lin, V.S.Y.2
-
34
-
-
77952340878
-
A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery
-
Park H.S., Kim C.W., Lee H.J., Choi J.H., Lee S.G., Yun Y.P., et al. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery. Nanotechnology 2010, 21:225101.
-
(2010)
Nanotechnology
, vol.21
, pp. 225101
-
-
Park, H.S.1
Kim, C.W.2
Lee, H.J.3
Choi, J.H.4
Lee, S.G.5
Yun, Y.P.6
-
35
-
-
84861990699
-
Immunization of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 protein
-
Guo H.C., Feng X.M., Sun S.Q., Wei Y.Q., Sun D.H., Liu X.T., et al. Immunization of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 protein. Virol J 2012, 9:108.
-
(2012)
Virol J
, vol.9
, pp. 108
-
-
Guo, H.C.1
Feng, X.M.2
Sun, S.Q.3
Wei, Y.Q.4
Sun, D.H.5
Liu, X.T.6
-
36
-
-
67650360788
-
Preparation of siliceous vesicles with adjustable sizes, wall thickness, and shapes
-
Yu M.H., Zhang J., Yuan P., Wang H.N., Liu N., Wang Y.H., et al. Preparation of siliceous vesicles with adjustable sizes, wall thickness, and shapes. Chem Lett 2009, 38:442-443.
-
(2009)
Chem Lett
, vol.38
, pp. 442-443
-
-
Yu, M.H.1
Zhang, J.2
Yuan, P.3
Wang, H.N.4
Liu, N.5
Wang, Y.H.6
-
37
-
-
84856253594
-
Controlled release of volatile (-)-menthol in nanoporous silica materials
-
Zhang J., Yu M.H., Yuan P., Lu G.Q., Yu C.Z. Controlled release of volatile (-)-menthol in nanoporous silica materials. J Incl Phenom Macrocycl Chem 2011, 71:593-602.
-
(2011)
J Incl Phenom Macrocycl Chem
, vol.71
, pp. 593-602
-
-
Zhang, J.1
Yu, M.H.2
Yuan, P.3
Lu, G.Q.4
Yu, C.Z.5
-
38
-
-
84907267381
-
-
[cited 16.04.12]. Merck.
-
Bovilis BVD. [cited 16.04.12]. Merck.
-
-
-
-
39
-
-
0037247932
-
Effect of passive immunity on the development of a protective immune response against bovine viral diarrhea virus in calves
-
Ridpath J.E., Neill J.D., Endsley J., Roth J.A. Effect of passive immunity on the development of a protective immune response against bovine viral diarrhea virus in calves. Am J Vet Res 2003, 64:65-69.
-
(2003)
Am J Vet Res
, vol.64
, pp. 65-69
-
-
Ridpath, J.E.1
Neill, J.D.2
Endsley, J.3
Roth, J.A.4
-
40
-
-
0024632564
-
Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody
-
Howard C.J., Clarke M.C., Brownlie J. Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody. Vet Microbiol 1989, 19:195-203.
-
(1989)
Vet Microbiol
, vol.19
, pp. 195-203
-
-
Howard, C.J.1
Clarke, M.C.2
Brownlie, J.3
-
41
-
-
0028035285
-
Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge
-
Howard C.J., Clarke M.C., Sopp P., Brownlie J. Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Vet Microbiol 1994, 42:171-179.
-
(1994)
Vet Microbiol
, vol.42
, pp. 171-179
-
-
Howard, C.J.1
Clarke, M.C.2
Sopp, P.3
Brownlie, J.4
-
42
-
-
79960664402
-
Endotoxin-free purification for the isolation of Bovine Viral Diarrhoea Virus E2 protein from insoluble inclusion body aggregates
-
Cavallaro A.S., Mahony D., Commins M., Mahony T.J., Mitter N. Endotoxin-free purification for the isolation of Bovine Viral Diarrhoea Virus E2 protein from insoluble inclusion body aggregates. Microb Cell Fact 2011, 10:57.
-
(2011)
Microb Cell Fact
, vol.10
, pp. 57
-
-
Cavallaro, A.S.1
Mahony, D.2
Commins, M.3
Mahony, T.J.4
Mitter, N.5
-
43
-
-
84907267380
-
-
iConcept Press
-
Cavallaro A., Mahony D., Mody K., Mahony T., Mitter N. Lots of bovine viral diarrhoea virus E2 protein - a subunit vaccine. Virology II - advanced issues 2014, iConcept Press, ISBN: 978-1-922227-45-4.
-
(2014)
Lots of bovine viral diarrhoea virus E2 protein - a subunit vaccine. Virology II - advanced issues
-
-
Cavallaro, A.1
Mahony, D.2
Mody, K.3
Mahony, T.4
Mitter, N.5
-
44
-
-
15044350604
-
Protein adsorption on the mesoporous molecular sieve silicate SBA-15: effects of pH and pore size
-
Katiyar A., Ji L., Smirniotis P., Pinto N.G. Protein adsorption on the mesoporous molecular sieve silicate SBA-15: effects of pH and pore size. J Chromatogr A 2005, 1069:119-126.
-
(2005)
J Chromatogr A
, vol.1069
, pp. 119-126
-
-
Katiyar, A.1
Ji, L.2
Smirniotis, P.3
Pinto, N.G.4
-
45
-
-
84919715000
-
Synthesis of silica vesicles with controlled entrance size for high loading, sustained release, and cellular delivery of therapeutical proteins
-
Zhang J., Karmakar S., Yu M., Mitter N., Zou J., Yu C. Synthesis of silica vesicles with controlled entrance size for high loading, sustained release, and cellular delivery of therapeutical proteins. Small 2014, 10.1002/smll.201401538.
-
(2014)
Small
-
-
Zhang, J.1
Karmakar, S.2
Yu, M.3
Mitter, N.4
Zou, J.5
Yu, C.6
-
46
-
-
77954065271
-
I-TASSER: a unified platform for automated protein structure and function prediction
-
Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010, 5:725-738.
-
(2010)
Nat Protoc
, vol.5
, pp. 725-738
-
-
Roy, A.1
Kucukural, A.2
Zhang, Y.3
-
47
-
-
39449115394
-
I-TASSER server for protein 3D structure prediction
-
Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinforma 2008, 9:40.
-
(2008)
BMC Bioinforma
, vol.9
, pp. 40
-
-
Zhang, Y.1
-
48
-
-
84873133718
-
Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry
-
El Omari K., Iourin O., Harlos K., Grimes J.M., Stuart D.I. Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry. Cell Rep 2013, 3:30-35.
-
(2013)
Cell Rep
, vol.3
, pp. 30-35
-
-
El Omari, K.1
Iourin, O.2
Harlos, K.3
Grimes, J.M.4
Stuart, D.I.5
-
49
-
-
1642457354
-
Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells
-
Zhao F., Malayev V., Rao V., Hussain M. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells. Pharm Res 2004, 21:144-148.
-
(2004)
Pharm Res
, vol.21
, pp. 144-148
-
-
Zhao, F.1
Malayev, V.2
Rao, V.3
Hussain, M.4
-
50
-
-
84889570779
-
Mesoporous silica nanoparticles enhance the cytotoxicity of curcumin
-
Jambhrunkar S., Karmakar S., Popat A., Yu M., Yu C. Mesoporous silica nanoparticles enhance the cytotoxicity of curcumin. RSC Adv 2014, 4:709-712.
-
(2014)
RSC Adv
, vol.4
, pp. 709-712
-
-
Jambhrunkar, S.1
Karmakar, S.2
Popat, A.3
Yu, M.4
Yu, C.5
-
51
-
-
71949125519
-
Role of surfactant and pH in dissolution of curcumin
-
Rahman S.M., Telny T.C., Ravi T.K., Kuppusamy S. Role of surfactant and pH in dissolution of curcumin. Indian J Pharm Sci 2009, 71:139-142.
-
(2009)
Indian J Pharm Sci
, vol.71
, pp. 139-142
-
-
Rahman, S.M.1
Telny, T.C.2
Ravi, T.K.3
Kuppusamy, S.4
-
52
-
-
77952754524
-
Uptake of functionalized mesoporous silica nanoparticles by human cancer cells
-
Fisichella M., Dabboue H., Bhattacharyya S., Lelong G., Saboungi M.L., Warmont F., et al. Uptake of functionalized mesoporous silica nanoparticles by human cancer cells. J Nanosci Nanotechnol 2010, 10:2314-2324.
-
(2010)
J Nanosci Nanotechnol
, vol.10
, pp. 2314-2324
-
-
Fisichella, M.1
Dabboue, H.2
Bhattacharyya, S.3
Lelong, G.4
Saboungi, M.L.5
Warmont, F.6
-
53
-
-
78650765253
-
Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye
-
Guo H., Qian H., Sun S., Sun D., Yin H., Cai X., et al. Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye. Chem Cent J 2011, 5:1.
-
(2011)
Chem Cent J
, vol.5
, pp. 1
-
-
Guo, H.1
Qian, H.2
Sun, S.3
Sun, D.4
Yin, H.5
Cai, X.6
-
54
-
-
67650338048
-
Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles
-
Lu F., Wu S.-H., Hung Y., Mou C.-Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009, 5:1408-1413.
-
(2009)
Small
, vol.5
, pp. 1408-1413
-
-
Lu, F.1
Wu, S.-H.2
Hung, Y.3
Mou, C.-Y.4
-
55
-
-
80053578495
-
The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis
-
Lee S., Yun H.-S., Kim S.-H. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 2011, 32:9434-9443.
-
(2011)
Biomaterials
, vol.32
, pp. 9434-9443
-
-
Lee, S.1
Yun, H.-S.2
Kim, S.-H.3
-
56
-
-
67349180163
-
Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes
-
Fisichella M., Dabboue H., Bhattacharyya S., Saboungi M.-L., Salvetat J.-P., Hevor T., et al. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol Vitro 2009, 23:697-703.
-
(2009)
Toxicol Vitro
, vol.23
, pp. 697-703
-
-
Fisichella, M.1
Dabboue, H.2
Bhattacharyya, S.3
Saboungi, M.-L.4
Salvetat, J.-P.5
Hevor, T.6
-
57
-
-
49549098376
-
Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells
-
Huang D.-M., Chung T.-H., Hung Y., Lu F., Wu S.-H., Mou C.-Y., et al. Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells. Toxicol Appl Pharmacol 2008, 231:208-215.
-
(2008)
Toxicol Appl Pharmacol
, vol.231
, pp. 208-215
-
-
Huang, D.-M.1
Chung, T.-H.2
Hung, Y.3
Lu, F.4
Wu, S.-H.5
Mou, C.-Y.6
-
58
-
-
77649191565
-
Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
-
Heikkila T., Santos HlA., Kumar N., Murzin D.Y., Salonen J., Laaksonen T., et al. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells. Eur J Pharm Biopharm 2010, 74:483-494.
-
(2010)
Eur J Pharm Biopharm
, vol.74
, pp. 483-494
-
-
Heikkila, T.1
Santos, H.2
Kumar, N.3
Murzin, D.Y.4
Salonen, J.5
Laaksonen, T.6
-
59
-
-
49649100580
-
The biocompatibility of mesoporous silicates
-
Hudson S.P., Padera R.F., Langer R., Kohane D.S. The biocompatibility of mesoporous silicates. Biomaterials 2008, 29:4045-4055.
-
(2008)
Biomaterials
, vol.29
, pp. 4045-4055
-
-
Hudson, S.P.1
Padera, R.F.2
Langer, R.3
Kohane, D.S.4
-
60
-
-
77955613395
-
Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals
-
Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
-
(2010)
Small
, vol.6
, pp. 1794-1805
-
-
Lu, J.1
Liong, M.2
Li, Z.3
Zink, J.I.4
Tamanoi, F.5
-
61
-
-
33845231619
-
Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human Cancer cells
-
Slowing I., Trewyn B.G., Lin V.S.Y. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human Cancer cells. J Am Chem Soc 2006, 128:14792-14793.
-
(2006)
J Am Chem Soc
, vol.128
, pp. 14792-14793
-
-
Slowing, I.1
Trewyn, B.G.2
Lin, V.S.Y.3
-
62
-
-
34547838187
-
Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs
-
Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3:1341-1346.
-
(2007)
Small
, vol.3
, pp. 1341-1346
-
-
Lu, J.1
Liong, M.2
Zink, J.I.3
Tamanoi, F.4
-
63
-
-
46749123819
-
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers
-
Slowing I.I., Vivero-Escoto J.L., Wu C.W., Lin V.S. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008, 60:1278-1288.
-
(2008)
Adv Drug Deliv Rev
, vol.60
, pp. 1278-1288
-
-
Slowing, I.I.1
Vivero-Escoto, J.L.2
Wu, C.W.3
Lin, V.S.4
-
64
-
-
0034777178
-
Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid
-
Raghuvanshi R.J., Mistra A., Talwar G.P., Levy R.J., Labhasetwar V. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. J Microencapsul 2001, 18:723-732.
-
(2001)
J Microencapsul
, vol.18
, pp. 723-732
-
-
Raghuvanshi, R.J.1
Mistra, A.2
Talwar, G.P.3
Levy, R.J.4
Labhasetwar, V.5
-
65
-
-
0026636415
-
Parameters affecting the immunogenicity of microencapsulated tetanus toxoid
-
Esparza I., Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 1992, 10:714-720.
-
(1992)
Vaccine
, vol.10
, pp. 714-720
-
-
Esparza, I.1
Kissel, T.2
-
66
-
-
34247117348
-
Adjuvant effects of saponins on animal immune responses
-
Rajput Z.I., Hu S.H., Xiao C.W., Arijo A.G. Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B 2007, 8:153-161.
-
(2007)
J Zhejiang Univ Sci B
, vol.8
, pp. 153-161
-
-
Rajput, Z.I.1
Hu, S.H.2
Xiao, C.W.3
Arijo, A.G.4
|